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Abstract We studied the occurrence of sick leave and work
disability, the presence of workplace adaptations and the
usage of professional guidance related to working problems
inpatients withearly arthritis.Inclusion criteria were arthritis
symptoms of less than 2 years duration and a paid job at the
time of diagnosis. Assessments were done in connection
with an early arthritis clinic (EAC) at entry into the cohort
and 12 months thereafter by means of a questionnaire
comprising questions on sick leave (absenteeism from work
reported to the employer), work disability (receiving a full or
partial work disability pension), unemployment, work
adaptations and professional guidance related to working
problems. Fifty-seven of the 69 participants (83%) had an
arthritis symptom duration of <6 months. The number of
patients with sick leave due to arthritis in the past 12 months
decreased from 28 (41%) at study entry to 18 (26%) after
12 months of follow-up. The number of patients receiving a
work disability pension increased from 5 (7%) at study entry
to 13 (19%) after 12 months of follow-up (10 partial and 3
full). Sick leave in the 12 months before study entry
appeared to be the most important predictor of the institution
or increase in a work disability pension (odds ratio, 16.1;
95%CI, 1.8–142.8). Between study entry and follow-up, the
number of patients with workplace adaptations increased
from 20 (29%) to 28 (42%), whereas the number of patients
receiving vocational guidance decreased from 48 (70%) to
36 (52%). In patients with early arthritis and a paid job,
arthritis-related sick leave was common and occurred in part
before patients entered the EAC and a diagnosis was made.
About 20% of the patients became permanently work
disabled, with partial work disability being more common
than full work disability. Considerable proportions of
patients received workplace adaptations and professional
guidance with working problems.
Keywords Arthritis.Occupationalhealth.Sickleave.
Vocationalrehabilitation.Workdisability
Introduction
Rheumatoid arthritis (RA) and other chronic inflammatory
rheumatic diseases are disabling conditions that affect the
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Leiden, The Netherlandslives of individual patients in many ways. The prevalence
of work disability is high among patients with RA [1], as
well as other forms of chronic arthritis, such as ankylosing
spondylitis [2], systemic lupus erythematosus [3] and to a
lesser extent psoriatic arthritis [4, 5]. In RA patients, it was
found that most work disability develops rapidly after onset
[6], with recent studies showing work disability rates
among RA patients 1 year after diagnosis vary between
15 and 30% [7–9].
So far, research has focussed mainly on permanent
work disability and its determinants [10]. Over the recent
years, the interest in sick leave, which is considered to
precede permanent work disability in chronic arthritis, is
increasing. In cross-sectional studies in early RA (disease
duration <2 years), the proportions of patients on sick leave
varied from 5–55% [7, 11–13], whereas in follow-up studies,
50–60% of the patients reported sick leave over a period of
1y e a r[ 7, 14, 15].
Until now, the number of studies on work disability and
sick leave in early arthritis is confined to the situation after
diagnosis, with no data being available on the occurrence of
sick leave or permanent work disability in the preceding
period. In addition, little is known about the extent of
adaptations to the work place or guidance by health
professionals in these early stages of the disease.
The aim of this study was therefore to describe the
occurrence of sick leave and permanent work disability and
its predictors in the very early phases of the disease.
Moreover, this study aimed to describe the provision of
adaptations to the workplace and professional guidance in
patients with chronic arthritis.
Materials and methods
Patients
This work disability study was originally designed as a
multicenter study, including the Leiden University Medical
Center (LUMC) Leiden, the Haga-Leyenburg Teaching
Hospital and Bronovo Hospital, The Hague and the Reinier
de Graaf Hospital, Delft, The Netherlands. We aimed to
recruit patients in connection with two cohorts, the early
arthritis clinic [16] (EAC; LUMC patients only) and the
BeSt study [17] (LUMC, Haga-Leyenburg Teaching Hos-
pital, Bronovo Hospital and Reinier de Graaf Gasthuis).
BeSt is an abbreviation of treatment strategies (in Dutch:
BehandelStrategieën) for RA, with four drug treatment
strategies all aimed at achieving low disease activity being
compared in patients with early, active RA [17]. The
Medical Ethics Committees of all three participating
hospitals approved the protocol of this additional work
disability study.
Due to logistical problems, the actual recruitment of
patients in the period 2000–2003 has only been carried out
in connection with the EAC in the LUMC. The EAC is a
facility aimed at early diagnosis and treatment of arthritis,
including all patients suffering from arthritis in one or more
joints, an arthritis symptom duration of less than 2 years,
and not being diagnosed with gout, chondrocalcinosis or
traumatic arthritis or a serious disease other than a
rheumatic condition. General practitioners are requested to
refer patients with suspected arthritis as soon as possible;
all patients can be seen within 2 weeks after referral [16].
Only patients who had a paid job 12 months before the first
visit in connection with the EAC were included.
On average, a definite diagnosis was made within
2 weeks after the first visit in connection with the EAC.
At the time the present study was conducted, patients who
were diagnosed with RA were promptly treated with either
methotrexate or salazopyrine. RA patients fulfilling the
inclusion criteria for the BeSt study [RA according to the
American College of Rheumatology, formerly American
Rheumatism Association, criteria [18], a disease duration of
less than 2 years, aged 18 years or older and active disease
indicated by ≥6 of 66 swollen joints, ≥6 of 68 tender joints
and at least one of the following two criteria: an erythrocyte
sedimentation rate (ESR) of ≥28 mm/h or a global health
score of ≥20 mm on a 0–100 mm visual analogue scale
(VAS), where 0=best and 100=worst] were randomized to
four treatment groups. These groups included sequential
monotherapy (group 1), step-up combination therapy
(group 2), initial combination therapy with tapered high-
dose prednisone (group 3), or initial combination therapy
with infliximab (group 4). For patients failing on their
medication, the study protocol prescribed a number of
subsequent treatment steps [17].
All patients included in the work disability study gave
written informed consent.
Assessment methods
Assessments were done at study entry (at study inclusion of
the EAC cohort) and after 12 months of follow-up. Basic
sociodemographic and clinical data were obtained from the
baseline assessments of the EAC, whereas data on the
working situation and mental health were gathered by
means of additional questionnaires.
Sociodemographic and clinical characteristics
Sociodemographic variables included age, sex, status of
living (living with a partner yes/no) and education level,
divided into three categories: primary education (0–8 years),
secondary education (9–16 years) and higher vocational
education /university (17 years or more).
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(mm/h); (b) the Ritchie score, concerning pain in 26
selected joints on a scale of 0–3 (0=no pain and 3=worst
pain), with the final score ranging from 0–69 [19] and (c)
the patient’s global assessment of disease activity, pain and
fatigue on three separate VAS. All VAS were 10 cm
horizontal lines, with the anchors on the left being no
disease activity, no pain and no fatigue, whereas the
anchors on the right were the worst imaginable disease
activity, severe pain and severe fatigue.
Physical functioning was measured by the Health
Assessment Questionnaire (HAQ). The HAQ is a 20-item
questionnaire comprising eight domains of activities of
daily living, with the final score ranging from 0 (no
disability) to 3 (severe disability) [20].
Anxiety and depression were measured by means of a
Dutch version of the Hospital Anxiety and Depression
Scale (HADS) [21]. The higher the scores on the anxiety or
depression scales the more anxious or depressed the subject
is (range, 0–21 per scale).
Job characteristics, sick leave, work disability, work
adaptations and guidance with working problems
Current occupation was grouped into four categories: (1)
predominantly mental demands and absence of physical
demands,(2)acombinationofphysical andmentaleffort,(3)
lightphysicaldemandsand(4)heavyphysicaldemands[22].
Sick leave was defined as absenteeism with a duration of
2 weeks or more, related to the arthritic complaints and
reported to the employer. At the time the study was
conducted, in the Dutch social security regulations, the
maximum duration of sick leave was 1 year, and sick leave
could be either complete (reported sick for all hours that
one is engaged) or partial (reported sick for part of the
hours that one is engaged). The duration of sick leave in the
12 months before study entry and 1 year thereafter was
divided into four categories: (1) 2–4 weeks, (2) 1–3 months,
(3) 3–6 months, (4) 6–9 months and (5) 9–12 months.
Permanent work disability was defined as receiving a
complete or partial work disability pension related to the
rheumatic disease. In the Dutch social security regulations,
a partial work disability pension in combination with a part-
time job is common. In this situation, sick leave may occur
during the hours active at work.
The presence of material or immaterial adaptations at
the workplace (including adapted tools, adapted furniture,
reduction in tasks or duties, help of colleagues, flexible
working hours, opportunities for more breaks, less working
hours or reduced work pace) was recorded. Reduced
working hours were only considered as an adaptation at
work when this adaptation did not pertain to official,
incomplete sick leave.
Guidance with working problems was recorded by means
of a question concerning the receipt of help in maintaining the
job. Health professionals listed for giving help were: the
rheumatologist, occupational physician, general practitioner,
social worker, physical therapist, occupational therapist or
nurse. In addition, it was registered whether patients received
support from their employer and/or colleagues. Satisfaction
with the received guidance was recorded. In addition, patients
were asked by whom they would have liked to be helped more.
Background information on sick leave and work disability
Background information on sick leave and work disability
in the Dutch population in the period the study was
conducted was derived from the Internet site of the Dutch
Central Bureau of Statistics, http://www.cbs.nl.
Statistical analysis
Data entry was performed using Microsoft Office Access
2000. Statistical analyses were executed using SPSS 10.0 for
Windows.
Continuous variables were presented as medians with
ranges and categorical variables as number and percent-
ages. Comparisons of the median age and the sex
distribution of patients included in the study and all other
patients of 65 years or younger who entered the EAC
cohort in the study period were done by means of the
Mann–Whitney U and chi-square test, respectively.
Proportions of patients being on sick leave or receiving a
work disability pension at study entry and after 12 months
of follow-up were compared using McNemar tests for
paired comparisons of categorical data, whereas the average
numbers of hours per week patients were working were
compared by means of the Wilcoxon signed rank test.
These analyses were repeated excluding all patients with a
symptom duration >6 months at study entry.
Sociodemographic, disease and job characteristics in the
group of patients in whom the working situation deterio-
rated after 12 months of follow-up (defined as being
entitled a partial or full work disability pension for the first
time or changing from a partial to a full work disability
pension) and in the group of patients in whom the working
situation remained stable or improved (defined as receiving
no disability pension or the same partial work disability
pension at either time point of changing from a partial work
disability pension to no disability pension) were compared
by Mann–Whitney U and chi-square tests.
Then, a multivariate backward logistic regression analysis
on predictors of deterioration of the working status was
performed.Onlyvariablesthatshowedasignificantdifference
in the above-mentioned analysis (p values≤0.1) were entered
as independent variables in logistic regression analysis.
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workplace or vocational guidance in the past year at study
entry and after 12 months of follow up were compared by
the McNemar test, whereas the median total numbers of
workplace adaptations per patient at both time points were
compared by means of the Wilcoxon signed rank test.
Results
In the study period, in total, 418 patients entered the EAC
cohort. One hundred and five of these 418 patients (25.1%)
were older than 65 years. From the remaining 313 patients,
81 patients (25.9%) were found eligible and willing to
participate. The reasons for not being included were not
recorded on the individual level. A group of patients was
not eligible for the study because they were not having a
paid job 12 months before the first visit in connection with
the EAC cohort. In addition, a number of patients were
eligible but declined participation, and some patients were
not invited because of logistic reasons.
Twelve of the initially included patients were excluded
within 2 weeks after enrollment because a diagnosis of gout,
chondrocalcinosis, sarcoidosis or a non-rheumatic disease
was confirmed after additional diagnostic procedures so that
they did not meet the inclusion criteria for the EAC.
The 69 patients included in the study were younger
(median age, 42.0 years; range 18–64) than the 244 patients
in the EAC cohort aged 65 years or less who were not
included (median age, 48.0 years; range, 18–65; p=0.08).
Moreover, the proportion of female patients was lower in
the 69 included patients (38/69, 55%) than in the 244
patients who were not included (158/244, 65%; p=0.09).
Sociodemographic and disease characteristics, including
physical and mental function, of the 69 included patients
are shown in Table 1. In total, 69 patients were recruited
from the EAC cohort. Thirty-nine patients (57%) had
definite RA, 8 patients (12%) had probable RA, 10 (15%)
had psoriatic arthritis, 3 (3%) had spondylarthropathy and 9
(13%) had unclassified arthritis, with the arthritis still being
unclassified after 12 months of follow-up. Twelve of the 39
patients with definite RA also participated in the BeSt
study; two were randomized to treatment group 1, three to
treatment group 2, five to treatment group 3 and two to
treatment group 4.
In total, 6 patients (9%) had a symptom duration of
>1 year, 6 patients (9%) had a symptom duration between
6 months and 1 year and 57 patients (83%) had a symptom
duration of <6 months.
Overall, disease activity was moderate, with the median
VAS disease activity score being 5.3 (range, 0–10.0) cm,
the median ESR 20 (range, 2–105) mm/h and the median
Ritchie score being 6 (0–32).
Data on the working status are presented in Table 2. Patients
were distributed fairly evenly over the four job categories.
At study entry, 22 patients (32%) were currently on sick
leave. In The Netherlands, in the period 2000–2003, the
average proportion of persons on sick leave in the working
population ranged between 4.8 and 8.4%, depending on the
branch (public service or industry) [http://www.cbs.nl].
Twenty-eight patients reported sick leave over the past
12 months, whereas after 12 months follow-up, 18 patients
reported sick leave in the preceding period. This difference
was mainly accounted for by a decrease in the number of
patients reporting sick leave for periods of 1–3 months. In
total, 34 patients (49%) reported sick leave in either
12 months before study entry or 12 months thereafter. Of
the 27 patients who reported sick leave due to arthritis in
the past 12 months with a specific duration at study entry, 5
were partially or fully work disabled after 12 months of
follow up, 10 reported long-term sick leave (1–3 months), 4
reported short-term sick leave (2–4 weeks) and 8 reported
no sick leave due to arthritis.
Five patients (7%) received a partial disability pension at
study entry. In two of these patients, this entitlement was
Table 1 Sociodemographic and disease characteristics of 69 patients
with early arthritis
Characteristics n (%)
Sociodemographic characteristics
Age, in years; median (range) 42 (18–64)
Female patients, n (%) 38 (55)
Living with partner/family, n (%) 57 (83)
Educational level, n (%)
High 18 (26)
Medium 32 (46)
Low 19 (28)
Disease characteristics
Diagnosis, n (%)
RA (definite) 39 (57)
RA (probable) 8 (12)
Psoriatic arthritis 10 (15)
Arthritis unspecified 9 (13)
Spondylarthropathy 3 (4)
Duration of arthritis symptoms, in years;
median (range)
0.3 (0–2)
VAS, 0–10 cm; median (range)
Disease activity patient 5.3 (0–10.0)
Pain patient 4.7 (1.0–9.8)
Fatigue patient 4.8 (0–10.0)
ESR, in mm/hr; median (range) 20 (2–105)
Ritchie index (0–68); median (range) 6 (1–32)
HAQ (0–3); median (range) 0.63 (0–1.88)
HADS anxiety; median (range) 5 (0–16)
HADS depression; median (range) 4 (0–13)
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whereas in the other three patients, the disability pension
remained unchanged. In addition, eight patients (12%)
started receiving a work disability pension in the 12-month
follow-up period (one patient a full disability pension and
seven a partial disability pension).
In The Netherlands, the average proportion of employees
in the working age range (15–64 years) becoming work
disabled over a period of 1 year ranged between 1 and 1.1%
in the period the study was conducted (http://www.cbs.nl).
None of the patients became unemployed during follow-up.
A repetition of the analyses excluding the six patients
with a symptom duration of >1 year showed similar
results (data no shown).
Table 3 shows sociodemographic, disease and job
characteristics of patients in whom the work status
deteriorated (institution or extension of work disability
pension) and of patients in whom the working situation
improved or remained stable. In the patients in whom the
work status deteriorated, the proportions of patients with a
diagnosis of definite RA, the occurrence of sick leave in the
previous 12 months and a duration of sick leave >4 weeks
were significantly higher than in the group of patients in
whom the working status remained stable. Moreover,
patients in whom the working status deteriorated had a
significantly higher VAS disease activity compared to
patients in whom the working status remained stable or
improved.
In the multivariate logistic regression analysis, the occur-
renceofsickleavein12months beforestudyentrywasfound
to be the only significant predictor of deterioration of the
working situation (odds ratio, 16.1; 95%CI, 1.8–142.8).
The presence of material and immaterial adaptations at
the workplace is shown in Table 4. The number of patients
in whom the workplace was adapted increased from 20
(29%) at baseline to 28 patients (42%) after 1 year follow-
up. The numbers of patients using adapted tools or
furniture, flexible time-management or performing different
tasks increased significantly with time. Moreover, the
average number of workplace adaptations per patient
increased significantly.
Table 5 shows the guidance of other persons with the
aim of the maintenance of the paid job. At study entry, 48
patients (70%) and, in the follow-up period, 36 patients
(52%) received professional guidance, with the rheumatol-
ogist, general practitioner and physical therapist being the
most frequently mentioned health care professionals. The
proportions of patients being satisfied with the guidance
were the lowest for the occupational physician. Employers
and/or colleagues provided help in one third of patients, for
the large majority of patients to their satisfaction.
Thirteen patients (19%) would have liked to have more
guidance with problems at work, especially from their
rheumatologist, a nurse specialized in rheumatology or
from their employer.
Discussion
This study in patients with early chronic arthritis shows that
about half of the patients reported arthritis-related sick
leave, and 19% became permanently work disabled over a
period 1 year before and 1 year after entering an EAC
cohort. Partial work disability was more common than full
work disability, and sick leave appeared to be its most
important predictor. In addition, work place adaptations,
professional guidance and help from employer and/or
colleagues were common in this population.
Table 2 Working status in 69 patients with early arthritis
Study
entry
Follow-up
(12 months)
p value
a
Job characteristics
Occupational category,
n (%)
Mental demands 18 (26)
Mixed mental/physical
demands
14 (20)
Light physical demands 20 (29)
Heavy physical demands 17 (25)
Hours of work per week;
median (range)
36 (5–70) 34 (4–70)
b 0.455
Full-time employment,
n (%)
34 (50) 29 (42) 0.375
Sick leave
Current sick leave, n (%) 22 (32)
Sick leave for the past
12 months, n (%)
28 (41) 18 (26) 0.031
Extent of sick leave,
n (%)
Complete sick leave 15 (54) 12 (67)
Partial sick leave 7 (25) 3 (17)
Unknown 6 (21) 3 (17)
Duration of sick leave for
the past 12 months, n (%)
2–4 weeks 5 (18) 7 (41) 0.754
1–3 months 14 (50) 2 (12) 0.002
3–12 months 8 (29) 8 (44) 1.0
Unknown 1 (4) 1 (4) 1.0
Work disability
Work disability pension
Complete or partial,
n (%)
5 (7) 13 (19) 0.008
Complete, n (%) 0 3 (4) 0.250
Partial, n (%) 5 (7) 10 (15) 0.180
ap value of Wilcoxon signed rank test or McNemar where appropriate.
bOnly patients who did not start to receive a work disability pension
or an extension of a work disability pension were considered.
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are in accordance with those of previous follow-up studies
in patients with early arthritis, where sick leave rates of 50–
60% over a period of 1 year were reported [7, 14, 15]. As in
our study, 83% of the patients had a disease duration of less
than 6 months; our data on the occurrence of sick leave in
the 12 months before study entry suggest that in a
considerable proportion of patients, sick leave may occur
before they enter an EAC, and a diagnosis of arthritis has
been made. In our study, the occurrence of sick leave
decreased with time, a finding that cannot be completely
interpreted as a positive observation, as it was in part
explained by patients on sick leave becoming permanently
work disabled (Table 6).
In our study, 19% of the patients were permanently work
disabled after 2 years of follow-up. This figure is in the
same range or somewhat more favourable than work
disability rates found in previous studies in patients with
early RA [7–9]. In fact, our results may even be more
favourable, as work disability was partial in the majority of
patients, whereas in other studies, only complete job loss
was considered. It should be noted, however, that our study
Table 3 Deterioration of working status
a in 12 months follow up in 69 patients with early arthritis
More work disability,
n=10
Stable work (dis)ability
n=59
p value
b
Sociodemographic characteristics
Age, years; median (range) 42 (28–58) 44 (18–64) 0.484
Female patients, n (%) 5 (50) 33 (56) 0.996
Educational level, n (%)
High 5 (50) 13 (22) 0.141
Medium 3 (30) 29 (49) 0.435
Low 2 (20) 17 (29) 0.846
Disease characteristics
Diagnosis, n (%)
RA (definite) 9 (90) 30 (51) 0.049
RA (probable) 0 8 (14) 0.481
Arthritis unspecified 1 (10) 8 (14) 1.0
Psoriatic arthritis 0 10 (17) 0.356
Spondylarthropathy 0 3 (5) 1.0
Duration of symptoms, years; median (range) 0.4 (0–0.9) 0.3 (0–2) 0.955
VAS, 0–10 cm; median (range)
Disease activity patient 7.5 (4.1–9.8) 5.1 (0–10.0) 0.038
Pain patient 5.7 (2.1–9.8) 4.6 (1.0–9.6) 0.096
Fatigue patient 5.9 (5.0–9.8) 4.0 (0–10.0) 0.131
Disease activity
ESR, mm/h; median (range) 26 (6–105) 17 (2–93) 0.264
Ritchie index (0–68); median (range) 14 (2–17) 6 (1–32) 0.068
Physical and mental functioning
HAQ (0–3); median (range) 0.88 (0–1.75) 0.63 (0–1.88) 0.174
HADS anxiety; median (range) 6.5 (0–13) 5 (0–16) 0.650
HADS depression; median (range) 5 (1–13) 3 (0–11) 0.195
Job characteristics
Current occupational category, n (%)
Mental demands 3 (30) 15 (25) 1.0
Mixed mental/physical demands 3 (30) 11 (19) 0.689
Light physical demands 1 (10) 19 (32) 0.292
Heavy physical demands 3 (30) 14 (24) 0.977
Sick leave related to arthritis 12 months before study entry, n (%) 9 (90) 19 (32) 0.002
Duration of sick leave related to arthritis in 12 months before study entry, n (%)
2–4 weeks 0 5 (26) 0.767
1–3 months 5 (56) 9 (47) 0.036
3–12 months 4 (44) 5 (26) 0.026
aDeterioration of work status defined as starting to receive a work disability pension or altering from a partial to a full work disability pension
after 12 months of follow-up.
bp value of Mann–Whitney U test or chi-square where appropriate
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deterioration of the working situation appeared to be more
frequent among patients with a diagnosis of definite RA
than in patients with other forms of arthritis. Our results are
in concordance with the observation that the incidence of
permanent work disability among RA and AS patients
appears to be declining over the last decades, most probably
related to new developments in pharmacological therapy
[23–25]. Indeed, the patients included in our study were
promptly treated, with the medical treatment for the patients
with RA consisting of either monotherapy with methotrex-
ate or salazopyrine or treatment according to the BeSt
protocol [17].
In this study, the duration of symptoms varied among
patients, so that not all patients were at equal risk of
developing sick leave or work disability. The impact of the
symptom duration may however be limited, as one of our
analyses showed that symptom duration had no effect on
the development of more work disability in the follow-up
period of 12 months.
In this study, no control group was used for comparison.
Data from the Dutch Central Bureau of Statistics (http://
www.cbs.nl) indicate that there is a considerable “back-
ground risk” of sick leave and work disability in the general
population. However, as in this study, patients were
explicitly asked to report sick leave and work disability
due to arthritis; it is doubtful whether this background risk
needs to be taken into account. It appeared that sick leave
and work disability rates among patients with early arthritis
were considerably higher than those in the general
population; however, for valid comparisons, a separate
study with similar registration methods among patients with
early arthritis and the general population is needed.
With respect to the determinants of work disability,
similar to studies in RA [26], disease severity was, in
general higher, and physical and psychological functioning
worse among patients in whom the working status
deteriorated than in those in whom the working status
remained stable. The fact that the association of some
measures of disease severity or physical or psychological
functioning with changes in the working status did not
reach statistical significance may have been due to the
relatively small sample size of this study. Moreover, our
finding that the occurrence of sick leave in the 12 months
before study entry was associated with a deterioration of the
working situation is in concordance with the results of
another study by our group among another group of
patients with various form of chronic arthritis [27]. The
results of both studies underscore the importance of the
recognition of sick leave as a risk factor for work disability
in patients with chronic arthritis. Previously, it has been
questioned whether rheumatologists do sufficiently recog-
Table 4 Presence of material and immaterial adaptations at the
workplace in 69 patients with early arthritis
Study
entry,
n=69
Follow-up
(12 months),
n=66
p value
a
No. of patients with
adaptations, n (%)
20 (29) 28 (42) 0.134
No. of adaptations per
person
b; median (range)
2.5
(1–6)
3.0 (1–9) <0.001
Types of adaptations
Adapted tools/furniture,
n (%)
1 (3) 11 (17) 0.002
Different tasks (extra
education), n (%)
2 (3) 12 (18) 0.013
Reduction of tasks/duties,
n (%)
9 (13) 18 (27) 0.064
Help of colleagues, n (%) 9 (13) 15 (23) 0.210
Flexible working hours,
n (%)
10 (15) 7 (11) 0.581
Flexible time-management,
n (%)
7 (10) 17 (26) 0.021
Less working hours, n (%) 8 (12) 12 (18) 0.424
Reduced work pace, n (%) 5 (7) 7 (11) 0.774
ap value of McNemar test or Wilcoxon signed rank test where
appropriate.
bOnly considering patients with one or more adaptations.
Table 5 Usage of and satisfaction with professional guidance and
help of employers/colleagues with respect to arthritis-related problems
at work in 69 patients with early arthritis
Study entry Follow-up (12 months)
Usage Satisfaction Usage Satisfaction
Rheumatologist,
n (%)
37 (54) 35 (95) 21 (30) 21 (100)
General
practitioner,
n (%)
34 (49) 29 (85) 12 (17) 12 (100)
Physiotherapist,
n (%)
24 (35) 20 (83) 21 (30) 21 (100)
Occupational
physician,
n (%)
16 (23) 12 (75) 19 (28) 13 (68)
Social worker,
n (%)
6 (9) 6 (100) 4 (6) 4 (100)
Clinical nurse
specialist,
n (%)
6 (9) 6 (100) 9 (13) 8 (89)
Occupational
therapist, n (%)
5 (7) 5 (100) 9 (13) 8 (89)
Total 48 (70) 41 (59)
Employer/
colleagues,
n (%)
23 (33) 21 (91) 21 (30) 19 (91)
All values expressed as numbers (%)
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could be considered as one of its manifestations. Apart
from paying attention to the presence of sick leave, the use
of instruments that have been specifically developed for the
identification of those individuals with chronic arthritis
having difficulties at work could be helpful because by
using these tools, working problems could be recognized in
earlier stages. Examples of those instruments are the RA-
Work Instability Scale [29] and the Work Limitations
Questionnaire [30]. In addition, Detaille et al. [31] showed
which issues are important from the patients’ perspective
and recommended a topic list for various health profes-
sionals to use during consultations. So far, these instru-
ments are only partly validated, have been mainly used in
studies, and are not developed to be applied at the
individual level. At present, valid and brief questionnaires
specifically designed for clinical practice are not yet
available. It is however conceivable that simply asking
patients about working problems or sick leave is another
sensitive method to identify patients at risk of work
disability.
The results of this study show that over a period of
2 years, in 30–40% of the patients, the work situation was
adapted, about 30% received help from the employer or
colleagues and 60–70% of patients received professional
guidance to maintain their job. With respect to the
implementation of work place adaptations and help from
the employer or colleagues, these figures are in line with
those of a recent study in early RA patients [32]. In that
study, it was demonstrated that support and help of co-
workers, employer help, shortened work days, new skills
and a modified work station or equipment were among the
work-related factors that significantly ameliorated work
ability. With respect to professional guidance, a recent
study in Dutch employing RA patients with a short disease
duration found that according to the patients, the mobiliza-
tion of health care professionals would help them tackle
their threats to work ability [33].
In our study, patients were generally very appreciative of
help concerning their working problems, with the lowest
proportions of patients being satisfied obtained for the
occupational physician. In The Netherlands, the importance
of the role of occupational physician in the maintenance of
a paid job in patients with chronic diseases is generally
recognized. However, in a previous study, the communica-
tion between occupational physicians and rheumatologists
was found to be hampered [34], factor that could have
contributed to the relatively low satisfaction scores.
A limitation of the present study may be that the total
number of patients was relatively low, and various types of
chronic arthritis were included, hampering conclusions
about specific diagnosis groups. Moreover, in this study,
about 25% of all patients in the working age range
(<65 years) who entered the EAC participated in the work
disability study. This proportion is significantly lower than
the percentages of patients with a paid job at symptom
onset in similar age groups in early RA cohorts, with
frequencies ranging between 50 and 75% [11, 35–37]. As
the sociodemographic and clinical characteristics of the
non-participants were not systematically gathered, it
remains unclear to what extent the population included in
this study differs from all patients with early arthritis who
have a paid job at symptom onset. Given the probability of
selection bias, our results have to be interpreted with care.
In conclusion, this study in patients with early chronic
arthritis and a paid job showed that the occurrence of
arthritis-related sick leave, before and directly after a
diagnosis is made, is substantial. In contrast, full permanent
work disability developed in a relatively small minority.
Work place adaptations, professional guidance and help
from employers or colleagues to maintain a paid job were
fairly common. Future research should aim at the detection
of patients at risk for the development of sick leave and
permanent work disability, as well as the optimization of
the process of vocational guidance.
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Table 6 Working situation after 12 months of follow-up in 27 patients with early arthritis who reported sick leave at study entry (in one patient
the duration of sick leave was unknown)
Study entry Follow-up
Duration of sick
leave
Partial work
disability
Full work
disability
Sick leave
2–4 weeks
Sick leave
1–3 months
Sick leave
3–12 months
No sick
leave
2–4 weeks (n=5) 0 0 1 2 0 2
1–3 months (n=14) 2 1 3 1 3 4
3–12 months (n=8) 1 1 0 0 4 2
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